Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury

可可黄酮醇对心肌梗死面积和损伤后损伤的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): The major objective of this proposal is to characterize the ability of cocoa and the flavanol, epicatechin, to reduce short and long-term ischemia-reperfusion induced myocardial injury in rats. Furthermore, we wish to provide evidence for the ability of cocoa and epicatechin to reduce neutrophil-mediated myocardial ischemia-reperfusion (IR) injury via a nitric oxide (NO) dependent mechanism. Polyphenols are widely distributed in plants and are known as flavonoids. Evidence indicates a negative correlation between consumption of flavonoid-rich foods and incidence of cardiovascular (CVD) disease. Cocoa powder is more than 10% flavanols (catechin and epicatechin) by weight. Interest in the beneficial effects of flavonols emerged from observations in Kuna Indians who have a very low incidence of CVD and consume minimally processed cocoa beverages. There are clues as to the mechanisms that explain cocoa effects. The consumption of flavanol rich cocoa leads to vasodilation which can be reversed by the use of an NO synthesis inhibitor. Other beneficial effects include the inhibition of platelet and leucocyte adhesion, low-density lipoprotein oxidation, reactive oxygen species (ROS) generation, eicosanoid synthesis and insulin resistance. Recent reports associate the beneficial effects of cocoa to the actions of epicatechin. The consumption of epicatechin by humans reproduces the vasodilatory effects of cocoa as well as its antioxidant and insulin sensitizing actions. Vasodilatory effects can be replicated by the use of epicatechin metabolites on isolated blood vessel preparations. Preliminary studies performed in a rat model of myocardial IR injury indicate epicatechin can exert cardioprotective effects. Treatment also reduces myocardial inflammation. Interestingly injury appears to require the presence of blood borne cells. Given the well documented beneficial effects of cocoa derived flavanols on cardiovascular parameters it is possible that these compounds may significantly reduce tissue injury and ultimately, improve long term organ structure/function. The requirement of blood to mediate tissue injury also suggests the involvement of neutrophils. With these issues in mind we propose to examine the following specific aims: Aim 1 will test the hypothesis that the administration of cocoa or epicatechin to rats leads to a reduction in myocardial IR injury and improves long term outcome. Rats will be subjected to 45 min of IR injury. Infarct size as well as myocardial injury-induced changes in cardiac structure/function will be determined up to 4 weeks post IR. ROS generation, NO production and anti-inflammatory endpoints will be determined. Studies will include the use of dose-response schemes and plasma transfusions to test for the "transferability" of protection. Aim 2 will test the hypothesis that cocoa or epicatechin treatment reduces in vivo PMN adhesion/trapping as well as their activation state. Aim 3 will test the hypothesis that cocoa or epicatechin induced increases in nitric oxide modulate (at least in part) the anti-adhesive effects of flavanols on PMN. PUBLIC HEALTH RELEVANCE: The major goal of this proposal is to characterize the ability of cocoa derived flavanols specifically epicatechin, to reduce short and long-term ischemia-reperfusion induced heart injury and to identify the role played by inflammatory cells. Given the focus on the effects of dark chocolate related flavanols we therefore address a topic relevant to the field of complementary and alternative medicine.
描述(由申请人提供):该提案的主要目的是表征可可和黄烷醇、表儿茶素减少大鼠短期和长期缺血再灌注引起的心肌损伤的能力。此外,我们希望提供证据证明可可和表儿茶素能够通过一氧化氮(NO)依赖性机制减少中性粒细胞介导的心肌缺血再灌注(IR)损伤。多酚广泛分布于植物中,被称为黄酮类化合物。 有证据表明,食用富含类黄酮的食物与心血管 (CVD) 疾病的发病率呈负相关。可可粉中黄烷醇(儿茶素和表儿茶素)的重量含量超过 10%。对黄酮醇有益作用的兴趣源于对库纳印第安人的观察,他们的心血管疾病发病率非常低,并且饮用经过最低限度加工的可可饮料。关于解释可可效应的机制有一些线索。食用富含黄烷醇的可可会导致血管舒张,这可以通过使用一氧化氮合成抑制剂来逆转。其他有益作用包括抑制血小板和白细胞粘附、低密度脂蛋白氧化、活性氧 (ROS) 生成、类二十烷酸合成和胰岛素抵抗。最近的报告将可可的有益作用与表儿茶素的作用联系起来。人类食用表儿茶素可重现可可的血管舒张作用及其抗氧化和胰岛素增敏作用。通过在离体血管制剂上使用表儿茶素代谢物可以复制血管舒张作用。在大鼠心肌IR损伤模型中进行的初步研究表明表儿茶素可以发挥心脏保护作用。治疗还可以减少心肌炎症。 有趣的是,损伤似乎需要血源性细胞的存在。 鉴于可可源黄烷醇对心血管参数的有益作用已得到充分证明,这些化合物可能会显着减少组织损伤,并最终改善长期器官结构/功能。介导组织损伤需要血液也表明中性粒细胞的参与。考虑到这些问题,我们建议研究以下具体目标:目标 1 将检验以下假设:给大鼠施用可可或表儿茶素可减少心肌 IR 损伤并改善长期结果。大鼠将受到 45 分钟的红外线损伤。梗塞面积以及心肌损伤引起的心脏结构/功能变化将在 IR 后 4 周内确定。将确定 ROS 生成、NO 生成和抗炎终点。研究将包括使用剂量反应方案和血浆输注来测试保护的“可转移性”。目标 2 将检验可可或表儿茶素治疗可减少体内 PMN 粘附/捕获及其激活状态的假设。目标 3 将检验以下假设:可可或表儿茶素诱导一氧化氮增加,调节(至少部分)黄烷醇对 PMN 的抗粘连作用。 公共健康相关性:该提案的主要目标是表征可可衍生黄烷醇(特别是表儿茶素)的能力,以减少短期和长期缺血再灌注引起的心脏损伤,并确定炎症细胞所起的作用。鉴于重点关注黑巧克力相关黄烷醇的影响,因此我们讨论了与补充和替代医学领域相关的主题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Francisco J Villarreal其他文献

Francisco J Villarreal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Francisco J Villarreal', 18)}}的其他基金

Beneficial Effects of FPR Agonists on an Animal Model of Early Stage Heart Failure with Preserved Ejection Fraction
FPR 激动剂对射血分数保留的早期心力衰竭动物模型的有益作用
  • 批准号:
    10580246
  • 财政年份:
    2022
  • 资助金额:
    $ 19.31万
  • 项目类别:
Excess O-GlcNAc modification of proteins and myocardial fibrosis
蛋白质的过量 O-GlcNAc 修饰与心肌纤维化
  • 批准号:
    10265339
  • 财政年份:
    2018
  • 资助金额:
    $ 19.31万
  • 项目类别:
Targeting cellular bioenergetics for the prevention and treatment of diabetes
针对细胞生物能量学预防和治疗糖尿病
  • 批准号:
    8150760
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
可可黄酮醇对心肌梗死面积和损伤后损伤的影响
  • 批准号:
    7534759
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury
可可黄酮醇对心肌梗死面积和损伤后损伤的影响
  • 批准号:
    7921723
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
26th Annual Meeting of the North Am. Section of the ISHR
第26届北美年会。
  • 批准号:
    6837277
  • 财政年份:
    2004
  • 资助金额:
    $ 19.31万
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6758583
  • 财政年份:
    2002
  • 资助金额:
    $ 19.31万
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6612815
  • 财政年份:
    2002
  • 资助金额:
    $ 19.31万
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6542064
  • 财政年份:
    2002
  • 资助金额:
    $ 19.31万
  • 项目类别:
Adenosine Mediated Modulation of Cardiac Fibrosis
腺苷介导的心脏纤维化调节
  • 批准号:
    6895818
  • 财政年份:
    2002
  • 资助金额:
    $ 19.31万
  • 项目类别:

相似国自然基金

基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
  • 批准号:
    82305302
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
组胺通过调控Th1/Th2平衡促进宫腔粘连的机制研究
  • 批准号:
    82360298
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
宫腔粘连子宫内膜NK细胞异常破坏间质稳态致内膜纤维化的机制研究
  • 批准号:
    82371641
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
  • 批准号:
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
  • 批准号:
    32301204
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation
Layilin 作为血小板活化和血栓炎症的新型调节剂的作用
  • 批准号:
    10638243
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
  • 批准号:
    10735701
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Atraumatic Non-fibrotic Epicardial Pacing with E-Bioadhesive Devices
使用电子生物粘附装置进行无创伤性非纤维化心外膜起搏
  • 批准号:
    10637562
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Multi-modality optical imaging of single-cell dynamics using supercontinuum light source
使用超连续谱光源的单细胞动力学多模态光学成像
  • 批准号:
    10798646
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric Biomaterial
自适应压电生物材料抑制细菌粘附和破坏生物膜
  • 批准号:
    10668030
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了